These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30513027)

  • 1. Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review.
    Sunyoto T; Boelaert M; Meheus F
    Expert Rev Anti Infect Ther; 2019 Jan; 17(1):57-69. PubMed ID: 30513027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences.
    Adhikari SR; Maskay NM; Sharma BP
    Health Policy Plan; 2009 Mar; 24(2):129-39. PubMed ID: 19181674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
    Meheus F; Abuzaid AA; Baltussen R; Younis BM; Balasegaram M; Khalil EAG; Boelaert M; Musa AM
    Am J Trop Med Hyg; 2013 Dec; 89(6):1146-1153. PubMed ID: 24189368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of visceral leishmaniasis for households in Nepal.
    Rijal S; Koirala S; Van der Stuyft P; Boelaert M
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):838-41. PubMed ID: 16406035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "
    Sunyoto T; Adam GK; Atia AM; Hamid Y; Babiker RA; Abdelrahman N; Vander Kelen C; Ritmeijer K; Alcoba G; den Boer M; Picado A; Boelaert M
    Am J Trop Med Hyg; 2018 Apr; 98(4):1091-1101. PubMed ID: 29488462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.
    Adhikari SR; Supakankunti S
    J Vector Borne Dis; 2010 Sep; 47(3):127-39. PubMed ID: 20834081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of visceral leishmaniasis on households in Bangladesh.
    Anoopa Sharma D; Bern C; Varghese B; Chowdhury R; Haque R; Ali M; Amann J; Ahluwalia IB; Wagatsuma Y; Breiman RF; Maguire JH; McFarland DA
    Trop Med Int Health; 2006 May; 11(5):757-64. PubMed ID: 16640630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?
    McIntyre D; Thiede M; Dahlgren G; Whitehead M
    Soc Sci Med; 2006 Feb; 62(4):858-65. PubMed ID: 16099574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.
    Sarnoff R; Desai J; Desjeux P; Mittal A; Topno R; Siddiqui NA; Pandey A; Sur D; Das P
    Trop Med Int Health; 2010 Jul; 15 Suppl 2():42-9. PubMed ID: 20487423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
    Thornton SJ; Wasan KM; Piecuch A; Lynd LL; Wasan EK
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1312-9. PubMed ID: 20545513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal.
    Adhikari SR; Maskay NM
    Acta Trop; 2003 Sep; 88(1):1-2. PubMed ID: 12943969
    [No Abstract]   [Full Text] [Related]  

  • 12. The household costs of visceral leishmaniasis care in south-eastern Nepal.
    Uranw S; Meheus F; Baltussen R; Rijal S; Boelaert M
    PLoS Negl Trop Dis; 2013; 7(2):e2062. PubMed ID: 23469298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Household cost-of-illness of visceral leishmaniasis in Bihar, India.
    Sundar S; Arora R; Singh SP; Boelaert M; Varghese B
    Trop Med Int Health; 2010 Jul; 15 Suppl 2():50-4. PubMed ID: 20487419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
    Meheus F; Boelaert M; Baltussen R; Sundar S
    Trop Med Int Health; 2006 Nov; 11(11):1715-24. PubMed ID: 17054752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insecticide resistance in phlebotomine sandflies in Southeast Asia with emphasis on the Indian subcontinent.
    Dhiman RC; Yadav RS
    Infect Dis Poverty; 2016 Nov; 5(1):106. PubMed ID: 27817749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmaniasis and poverty.
    Alvar J; Yactayo S; Bern C
    Trends Parasitol; 2006 Dec; 22(12):552-7. PubMed ID: 17023215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmaniasis impact and treatment access.
    den Boer M; Argaw D; Jannin J; Alvar J
    Clin Microbiol Infect; 2011 Oct; 17(10):1471-7. PubMed ID: 21933305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of TB diagnosis and treatment in South Africa.
    Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
    Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring access to essential health products: Lessons from Colombia's leishmaniasis control and elimination initiative.
    Vlassoff C; Giron N; Vera Soto MJ; Maia-Elkhoury ANS; Lal A; Castellanos LG; Almeida G; Lim C
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011752. PubMed ID: 38039275
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.